Chronic heart failure in adults

in the dose or type of their heart failure medication. Adults with chronic heart failure are seen by the appropriate healthcare professional within 2 weeks of any change in the dose or type of medication they are taking for heart failure, to check for any problems and make sure that the medication is working. Source guidance Chronic heart failure in adults: diagnosis and management. NICE guideline NG106 (2018, updated 2025), recommendations 1.8.1 and 1.8.3 Definitions of terms used in this quality statement Review when medication is changed Review should include as a minimum: • clinical assessment of functional capacity, fluid status, cardiac rhythm (minimum of examining the pulse), cognitive status and nutritional status • review of medication, including need for changes and possible side effects • an assessment of renal function • iron status and haemoglobin measurement. Reviews may need to be adjusted based on the medication that has been introduced or changed, for example testing within 2 weeks of introduction of a sodium-glucose co-transporter 2 inhibitor may show irregular results for some tests. More detailed monitoring is needed if the person has significant comorbidity or if their condition has deteriorated since the previous review. [Adapted from NICE's guideline on
